A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - nature.com
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - …, 2018 - pure.johnshopkins.edu
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

[HTML][HTML] A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - ncbi.nlm.nih.gov
B cell receptor (BCR) signaling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - …, 2018 - ui.adsabs.harvard.edu
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - econpapers.repec.org
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - hal.science
B cell receptor (BCR) signaling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - go.gale.com
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - ideas.repec.org
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …

[引用][C] A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster, S Roulland… - Nature, 2018 - cir.nii.ac.jp
A multiprotein supercomplex controlling oncogenic signalling in lymphoma | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

JD Phelan, RM Young, DE Webster… - …, 2018 - mayoclinic.elsevierpure.com
B cell receptor (BCR) signalling has emerged as a therapeutic target in B cell lymphomas,
but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a …